Q4 2024 Holdings
Filed 2025-02-13 | 214 holdings | $500.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $41.5M | 3,508,694 | 8.3% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $39.4M | 1,020,333 | 7.9% |
| EA Series Trust(BOXX) | ALPHA ARCH 1-3 | 02072L565 | $35.9M | 325,450 | 7.2% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $27.4M | 1,045,837 | 5.5% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $19.5M | 787,478 | 3.9% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $19.5M | 414,209 | 3.9% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $18.6M | 678,857 | 3.7% |
| Inhibikase Therapeutics Inc(IKT) | COM NEW | 45719W205 | $16.6M | 5,103,005 | 3.3% |
| Spdr SER TR(BIL) | BLOOMBERG 1-3 MO | 78468R663 | $12.0M | 131,786 | 2.4% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $11.1M | 1,513,393 | 2.2% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $10.4M | 841,541 | 2.1% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $9.8M | 71,402 | 2.0% |
| Perceptive Cap Solutions COR | CL A ORD SHS | G70077105 | $7.6M | 750,000 | 1.5% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $7.4M | 170,000 | 1.5% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $6.7M | 1,359,208 | 1.3% |
| Endeavor Group Hldgs Inc(0C3) | CL A COM | 29260Y109 | $6.6M | 210,729 | 1.3% |
| CG Oncology Inc(CGON) | COM | 156944100 | $6.2M | 215,750 | 1.2% |
| Anteris Technologies Global(AVR) | COM | 03675P102 | $5.9M | 1,052,968 | 1.2% |
| AA Mission Acquisition Corp | ORD SHS CL A | G1000R101 | $5.7M | 560,199 | 1.1% |
| Coherus Biosciences Inc | NOTE 1.500% 4/1 | 19249HAB9 | $5.5M | $5,625,000 | 1.1% |
| Xencor Inc(XNCR) | COM | 98401F105 | $5.4M | 234,607 | 1.1% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $5.2M | 2,077,251 | 1.0% |
| Protagonist Therapeutics Inc(PTGX)Call | COM | 74366E102 | $5.1M | 132,000 | 1.0% |
| Arbutus Biopharma Corp(ABUS) | COM | 03879J100 | $5.1M | 1,554,802 | 1.0% |
| Oaktree Acquisition Corp III | UNIT 10/04/2029 | G6717R120 | $5.1M | 500,000 | 1.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $4.9M | 40,002 | 1.0% |
| Sanofi(SNY) | SPONSORED ADR | 80105N105 | $4.8M | 99,600 | 1.0% |
| Spdr SER TR(XBI)Call | S&P BIOTECH | 78464A870 | $4.5M | 50,000 | 0.9% |
| Gossamer BIO Inc | NOTE 5.000% 6/0 | 38341PAA0 | $4.4M | $8,000,000 | 0.9% |
| Helix Acquisition Corp II | CL A ORD SHS | G4444H101 | $4.2M | 404,138 | 0.8% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $4.0M | 515,138 | 0.8% |
| Bridgebio Pharma Inc | NOTE 2.250% 2/0 | 10806XAD4 | $3.9M | $4,500,000 | 0.8% |
| Merus N V | COM | N5749R100 | $3.4M | 81,460 | 0.7% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $3.3M | 166,406 | 0.7% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $3.2M | 647,960 | 0.6% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $3.2M | 146,671 | 0.6% |
| Savara Inc(SVRA) | COM | 805111101 | $3.0M | 988,468 | 0.6% |
| Grace Therapeutics Inc(GRCE) | COM | 00439U104 | $2.9M | 773,635 | 0.6% |
| Monopar Therapeutics Inc(MNPR) | COM NEW | 61023L207 | $2.9M | 130,037 | 0.6% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $2.7M | 53,125 | 0.5% |
| Tectonic Therapeutic Inc(TECX) | COM | 878972108 | $2.7M | 58,708 | 0.5% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $2.7M | 211,400 | 0.5% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $2.6M | 154,027 | 0.5% |
| Aerovate Therapeutics Inc | COM | 008064107 | $2.5M | 928,016 | 0.5% |
| Korro BIO Inc(KRRO) | COM | 500946108 | $2.2M | 57,978 | 0.4% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $2.2M | 48,023 | 0.4% |
| A Spac III Acquisition Corp | UNIT 02/15/2029 | G0544A137 | $2.2M | 215,000 | 0.4% |
| Bridgebio Pharma Inc | NOTE 2.500% 3/1 | 10806XAB8 | $2.1M | $2,000,000 | 0.4% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $2.0M | 50,547 | 0.4% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $1.9M | 41,274 | 0.4% |